LaFleur & Godfrey’s Medtronic MDT Stock Holding History

LaFleur & Godfrey’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.37M	Sell	43,028 -7,897	-16%	-$637K	0.4%	55
2026 Q1	$4.41M	Sell	50,925 -849	-2%	-$81.3K	0.55%	49
2025 Q4	$4.97M	Buy	51,774 +5,620	+12%	+$546K	0.6%	48
2025 Q3	$4.4M	Buy	46,154 +6,218	+16%	+$572K	0.53%	48
2025 Q2	$3.48M	Sell	39,936 -596	-1%	-$50.5K	0.43%	55
2025 Q1	$3.64M	Buy	40,532 +609	+2%	+$54.5K	0.49%	56
2024 Q4	$3.19M	Sell	39,923 -12,796	-24%	-$1.11M	0.44%	58
2024 Q3	$4.75M	Sell	52,719 -2,072	-4%	-$174K	0.65%	46
2024 Q2	$4.31M	Sell	54,791 -4,035	-7%	-$331K	0.63%	46
2024 Q1	$5.13M	Buy	58,826 +553	+0.9%	+$47.2K	0.76%	44
2023 Q4	$4.8M	Sell	58,273 -13,971	-19%	-$1.06M	0.72%	45
2023 Q3	$5.66M	Sell	72,244 -9,606	-12%	-$804K	0.91%	37
2023 Q2	$7.21M	Buy	81,850 +2,250	+3%	+$194K	1.08%	31
2023 Q1	$6.42M	Sell	79,600 -6,679	-8%	-$544K	1.05%	30
2022 Q4	$6.71M	Sell	86,279 -25,727	-23%	-$2.09M	1.12%	30
2022 Q3	$9.04M	Sell	112,006 -11,784	-10%	-$1.06M	1.61%	20
2022 Q2	$11.1M	Buy	123,790 +20,951	+20%	+$2.12M	1.76%	18
2022 Q1	$11.4M	Buy	102,839 +15,377	+18%	+$1.62M	1.53%	24
2021 Q4	$9.05M	Buy	87,462 +68,512	+362%	+$7.93M	1.16%	31
2021 Q3	$2.38M	Hold	18,950	–	–	0.33%	70
2021 Q2	$2.35M	Buy	18,950 +13,140	+226%	+$1.65M	0.34%	70
2021 Q1	$686K	Hold	5,810	–	–	0.13%	73
2020 Q4	$681K	Hold	5,810	–	–	0.14%	75
2020 Q3	$604K	Sell	5,810 -550	-9%	-$55.2K	0.14%	78
2020 Q2	$583K	Buy	6,360 +99	+2%	+$9.49K	0.15%	58
2020 Q1	$565K	Hold	6,261	–	–	0.17%	59
2019 Q4	$710K	Buy	6,261 +270	+5%	+$29.6K	0.16%	57
2019 Q3	$651K	Sell	5,991 -350	-6%	-$36.5K	0.16%	55
2019 Q2	$618K	Buy	6,341 +600	+10%	+$54.8K	0.15%	57
2019 Q1	$523K	Sell	5,741 -800	-12%	-$71.6K	0.14%	55
2018 Q4	$595K	Hold	6,541	–	–	0.17%	54
2018 Q3	$643K	Sell	6,541 -335	-5%	-$31K	0.15%	55
2018 Q2	$589K	Hold	6,876	–	–	0.15%	53
2018 Q1	$552K	Sell	6,876 -855	-11%	-$70.5K	0.14%	54
2017 Q4	$624K	Hold	7,731	–	–	0.15%	58
2017 Q3	$601K	Sell	7,731 -1,375	-15%	-$114K	0.16%	58
2017 Q2	$808K	Sell	9,106 -1,095	-11%	-$92.3K	0.21%	56
2017 Q1	$822K	Sell	10,201 -7,425	-42%	-$580K	0.22%	57
2016 Q4	$1.25M	Hold	17,626	–	–	0.35%	52
2016 Q3	$1.52M	Sell	17,626 -4,880	-22%	-$425K	0.44%	49
2016 Q2	$1.95M	Buy	22,506 +95	+0.4%	+$7.68K	0.58%	50
2016 Q1	$1.68M	Sell	22,411 -6,850	-23%	-$516K	0.51%	49
2015 Q4	$2.25M	Sell	29,261 -2,835	-9%	-$213K	0.67%	47
2015 Q3	$2.15M	Sell	32,096 -2,400	-7%	-$177K	0.64%	44
2015 Q2	$2.56M	Sell	34,496 -545	-2%	-$41.6K	0.71%	44
2015 Q1	$2.73M	Buy	35,041 +475	+1%	+$36K	0.73%	43
2014 Q4	$2.5M	Buy	34,566 +341	+1%	+$23.7K	0.67%	46
2014 Q3	$2.12M	Buy	34,225 +25,055	+273%	+$1.59M	0.58%	51
2014 Q2	$585K	Buy	9,170 +700	+8%	+$42.5K	0.16%	66
2014 Q1	$521K	Hold	8,470	–	–	0.14%	62
2013 Q4	$486K	Hold	8,470	–	–	0.13%	64
2013 Q3	$451K	Sell	8,470 -900	-10%	-$48.4K	0.13%	63
2013 Q2	$482K	Buy	+9,370	New	+$463K	0.14%	62

Other funds holding MDT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

GAM

Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

LaFleur & Godfrey's MDT Position: Q2 2026 in Review

LaFleur & Godfrey reduced its Medtronic (MDT) stake by 16% in Q2 2026, selling an estimated $637K and leaving 43,028 shares worth $3.37M. The position accounts for 0.4% of the portfolio, ranked #55.

LaFleur & Godfrey first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.4M in Q1 2022. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

LaFleur & Godfrey held 43,028 shares of Medtronic worth $3.37M as of Q2 2026.
LaFleur & Godfrey sold 7,897 Medtronic shares in Q2 2026, an estimated $637K.
Medtronic made up 0.4% of LaFleur & Godfrey's portfolio in Q2 2026, its #55 holding.
LaFleur & Godfrey first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
LaFleur & Godfrey's Medtronic position peaked at $11.4M in Q1 2022.
961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.